2009
DOI: 10.1086/605033
|View full text |Cite
|
Sign up to set email alerts
|

Rotavirus Vaccination: Cost‐Effectiveness and Impact on Child Mortality in Developing Countries

Abstract: Introduction of rotavirus vaccines into the world's poorest countries is very cost-effective and is projected to substantially reduce childhood mortality.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
75
0
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 74 publications
(76 citation statements)
references
References 56 publications
0
75
0
1
Order By: Relevance
“…The Gn pig-adapted (passage 23) HRV Wa G1P [8] strain (virHRV) was administered orally to Gn pigs at a dose of 10 6 fluorescent focus units (FFU) in 3 ml of minimum essential medium (MEM; Thermo Fisher Scientific, Waltham, MA, USA), immediately after oral administration of 3 ml of 100 mM sodium bicarbonate to reduce gastric acidity as described previously (14).…”
Section: Methodsmentioning
confidence: 99%
“…The Gn pig-adapted (passage 23) HRV Wa G1P [8] strain (virHRV) was administered orally to Gn pigs at a dose of 10 6 fluorescent focus units (FFU) in 3 ml of minimum essential medium (MEM; Thermo Fisher Scientific, Waltham, MA, USA), immediately after oral administration of 3 ml of 100 mM sodium bicarbonate to reduce gastric acidity as described previously (14).…”
Section: Methodsmentioning
confidence: 99%
“…Two primary rotavirus vaccines have been certified (RotaTeq, Merck & Co, and Rotarix, GSK Biologicals) in major countries of the world and are slated to be incorporated across the developing world (Ruiz-Palacios et al, 2006;Vesikari et al, 2006). The vaccination is usually administered to children under 1 year of age and typically costs from $1 to $7 per dose (Atherly et al, 2009). …”
Section: Discussionmentioning
confidence: 99%
“…Успешное применение ротавирусных вакцин в стра-нах Латинской Америки также позволило подсчитать потенциальную эффективность рутинной иммунизации, которая к 2025 г. позволит предупредить 141 случай амбулаторных посещений по поводу РВГЭ и сохранит более 16 000 детских жизней на каждую 1000 вакцини-рованных младенцев [72].…”
Section: вопросы современной педиатрииunclassified